Highlights
- •In the United States, there is limited screening of women aged 65 years or more for osteoporosis.
- •Significant racial/ethnic disparities exist in the diagnosis and treatment of osteoporosis; systems-, provider-, and patient-level factors contribute to these disparities.
- •The current fracture risk calculators were primarily validated in white populations, making their generalizability to racial/ethnic minority populations unclear.
Abstract
Osteoporosis and fragility fractures result in significant morbidity and mortality
and contribute to substantial healthcare costs. Despite being a treatable disease,
osteoporosis remains both underdiagnosed and undertreated in the US general population,
with significant disparities in care between non-White and White women. These disparities
are evident from screening to post-fracture treatment. Non-White women are less likely
to be screened for osteoporosis, to be prescribed pharmacotherapy, or to receive treatment
post-fracture; furthermore, the mortality rate after fracture is higher in non-White
women. Given existing diagnostic and treatment disparities, additional studies and
interventions are needed to optimize the bone health of Asian, Black, Hispanic, and
Native American women, and to reduce morbidity and mortality from osteoporosis and
fragility fractures.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to MaturitasAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Risk assessment tools for osteoporosis screening in postmenopausal women: a systematic review.Curr. Osteoporos. Rep. 2015; 13: 287-301
- Trends and disparities in osteoporosis screening among women in the United States, 2008-2014.Am. J. Med. 2017; 130: 306-316
- Racial disparities exist in outcomes after major fragility fractures.J. Am. Geriatr. Soc. 2020; 68: 1803-1810
- Screening for osteoporosis: U.S. preventive services task force recommendation statement.Ann. Intern. Med. 2011; 154: 356-364
- Disparities in osteoporosis screening between at-risk African-American and white women.J. Gen. Intern. Med. 2005; 20: 847-851
- Clinician's guide to prevention and treatment of osteoporosis.Osteoporos. Int. 2014; 25: 2359-2381
- Osteoporosis risk assessment and ethnicity: validation and comparison of 2 clinical risk stratification instruments.J. Gen. Intern. Med. 2006; 21: 630-635
- Osteoporosis and fracture risk in women of different ethnic groups.J. Bone Miner. Res. 2005; 20: 185-194
- Race and sex differences in mortality following fracture of the hip.Am. J. Public Health. 1992; 82: 1147-1150
- Differences in outcome between black and white elderly hip fracture patients.J. Chronic Dis. 1987; 40: 931-938
- American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis- 2020 update executive summary.Endocr. Pract. 2020; 26: 564-570
- Osteoporosis healthcare disparities in postmenopausal women.J. Womens Health. 2012; 21 (Larchmt): 1232-1236
- Racial and socioeconomic disparities in bone density testing before and after hip fracture.J. Gen. Intern. Med. 2007; 22: 1239-1245
- Racial disparities in osteoporosis prevention in a managed care population.South. Med. J. 2003; 96: 445-451
- Osteoporosis screening is unjustifiably low in older African-American women.J. Natl. Med. Assoc. 2004; 96: 461-467
- Trends and disparities in self-reported and measured osteoporosis among US adults, 2007-2014.J. Clin. Med. 2019; 8: 2052
- Racial and ethnic disparities in bone health and outcomes in the United States.J. Bone Miner. Res. 2021; 36: 1881-1905
- African Americans: disparities in health care access and utilization.Health Soc. Work. 2005; 30: 265-270
- The role of socioeconomic status on hip fracture.Osteoporos. Int. 2006; 17: 1562-1568
- Unequal treatment: Confronting Racial and Ethnic Disparities in Health Care. xvi. National Academy Press, Washington, D.C.2003: 764
- Bone Health and Osteoporosis: A Report of the Surgeon General.Department of Health and Human Services, Office of the Surgeon General, Rockville, MD: U.S.2004
- BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures.J. Bone Miner. Res. 2003; 18: 1947-1954
- Quality in dual-energy X-ray absorptiometry scans.Bone,. 2017; 104: 13-28
- Evaluating the performance of the WHO international reference standard for osteoporosis diagnosis in postmenopausal women of varied polygenic score and race.J. Clin. Med. 2020; 9: 499
- Bone health during the menopause transition and beyond.Obstet. Gynecol. Clin. North Am. 2018; 45: 695-708
- Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry.J. Clin. Densitom. 2013; 16: 455-466
- A brief history of FRAX.Arch. Osteoporos. 2018; 13: 118
- The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.Osteoporos. Int. 2007; 18: 1033-1046
- Potential extensions of the US FRAX algorithm.J. Osteoporos. 2012; 2012528790
- The effects of a FRAX revision for the USA.Osteoporos. Int. 2010; 21: 35-40
- Updated fracture incidence rates for the US version of FRAX.Osteoporos. Int. 2010; 21: 25-33
- The assessment of fracture risk.J. Bone Joint Surg. Am. 2010; 92: 743-753
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.Osteoporos. Int. 2008; 19: 449-458
- Hidden in plain sight - reconsidering the use of race correction in clinical algorithms.N. Engl. J. Med. 2020; 383: 874-882
- Considering race and ethnicity in the management of bone health.J. Bone Miner. Res. 2021; 36: 1879-1880
- FRAX and ethnicity.Osteoporos. Int. 2020; 31: 2063-2067
- Racial disparities, FRAX, and the care of patients with osteoporosis.Osteoporos. Int. 2020; 31: 2069-2071
- Hip fracture in women without osteoporosis.J. Clin. Endocrinol. Metab. 2005; 90: 2787-2793
- Type 2 diabetes and bone.J. Bone Miner. Res. 2012; 27: 2231-2237
- Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification.Clin. Diabetes Endocrinol. 2018; 4: 9
- Osteoporosis and risk of fracture in patients with diabetes: an update.Aging Clin. Exp. Res. 2011; 23: 84-90
- Diabetes mellitus as a risk factor for hip fracture in mexican american older adults.J. Gerontol. A Biol. Sci. Med. Sci. 2002; 57: M648-M653
- Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study.Arch. Intern. Med. 2005; 165: 1612-1617
- Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry.J. Bone Miner. Res. 2018; 33: 1923-1930
- Osteoporosis in patients with diabetes mellitus.J. Bone Miner. Res. 2007; 22: 1317-1328
- Diagnosis and management of bone fragility in diabetes: an emerging challenge.Osteoporos. Int. 2018; 29: 2585-2596
- FRAX underestimates fracture risk in patients with diabetes.J. Bone Miner. Res. 2012; 27: 301-308
- Type 2 diabetes mellitus unawareness, prevalence, trends and risk factors: national health and nutrition examination survey (NHANES) 1999-2010.J. Int. Med. Res. 2017; 45: 594-609
- Type 2 diabetes in east Asians: similarities and differences with populations in Europe and the United States.Ann. N. Y. Acad. Sci. 2013; 1281: 64-91
- Prevalence and trends of chronic kidney disease and its risk factors among US adults: an analysis of NHANES 2003-18.Prev. Med. Rep. 2020; 20101193
- Management of osteoporosis in chronic kidney disease.Intern. Med. 2017; 56: 3271-3276
- Osteoporosis in patients with chronic kidney diseases: a systemic review.Int. J. Mol. Sci. 2020; 21: 6846
- Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.J. Cachexia Sarcopenia Muscle. 2017; 8: 686-701
- Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. preventive services task force.Ann. Intern. Med. 2002; 137: 529-541
- Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture.J. Rheumatol. 2005; 32: 870-875
- Disparities in osteoporosis treatments.Osteoporos. Int. 2016; 27: 509-519
- Racial disparity in treatment of osteoporosis after diagnosis.Osteoporos. Int. 2006; 17: 1653-1658
- Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender.J. Gen. Intern. Med. 2009; 24: 956-962
- Osteoporosis in the women's health initiative: another treatment gap?.Am. J. Med. 2017; 130: 937-948
- Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data.Osteoporos. Int. 2014; 25: 2199-2208
- The relationship of race/ethnicity and social class to hormone replacement therapy: results from the third national health and nutrition examination survey 1988-1994.Menopause. 2002; 9: 264-272
- Ethnic differences in hormone replacement prescribing patterns.J. Gen. Intern. Med. 1999; 14: 663-669
- Ethnic disparity in the treatment of women with established low bone mass.J. Am. Med. Womens Assoc. (1972). 2003; 58: 173-177
- Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010.J. Am. Geriatr. Soc. 2013; 61: 1855-1862
- FRAX: re-adjust or re-think.Arch. Osteoporos. 2020; 15: 150
Article info
Publication history
Published online: October 24, 2021
Accepted:
October 19,
2021
Received in revised form:
October 6,
2021
Received:
August 10,
2021
Identification
Copyright
© 2021 Elsevier B.V. All rights reserved.
